The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.
ESMO pays tribute to Prof. José Baselga. 'Undoubtedly a giant of oncology, one of the most innovative scientists, an amazing mentor. He gave a lot to cancer research, cancer professionals and cancer patients: now we all must continue his legacy.'
Bonjour Paris 🇫🇷
#ESMO22
will be opening its onsite & online doors today 🙌 Five fantastic days of world-class science, practice-changing data & state-of-the-art education. In three words - science, community,
#sustainability
.
#Medtwitter
#OncTwitter
We are pleased to announce
@MyriamChalabi
is the 2023 recipient of the ESMO José Baselga Fellowship for Clinician Scientists.
This fellowship, supported by AZ, provides the resources & mentorship needed by physicians to develop as clinician-scientists.
👉
Just out 10 ESMO statements on
#Covid19
#vaccination
in
#cancer
patients to address key issues on
#vaccines
: efficacy/safety of vaccines, interaction w/ antineoplastic therapies, immune response in pts, prioritisatn/distribution planning
#COVID
-19vaccines
#ESMO23
truly delivered on the ESMO promise to stand by the side of oncologists & make a difference in the lives of people with cancer. Many thanks to all of you who made this happen and see you in Barcelona for
#ESMO24
.
@Silke_Gillessen
@AndresC27622123
#ESMO19
... exceptional, there's no other word! Thank you to all the attendees, Chairs, Speakers and staff for making this moment happen. Safe travels home and see you next year in Madrid for
#ESMO20
🙌
With great sadness we join the oncology community in mourning the passing of Angelo Di Leo, a giant in the
#breastcancer
field and recipient of the ESMO Lifetime Achievement Award in 2019 and member of the
@Annals_Oncology
Editorial Board. Our thoughts are with his loved ones.
#ESMO23
: That exciting time of the year 🙌Almost all late-breaking abstract titles and authors are now online. Head to the programme and check out all the impressive science you can look forward to. This year we received 4,565 abstracts, an increase of +30% (YOY). See you in…
New ESMO Guideline: Oncogene-Addicted
#mNSCLC
. Developed due to rapid advances in biomarker identification & targeted therapies; updated recommendations & tx algorithms on new & clinically relevant biomarker identification, targeting & adv disease managemt
Like all good things
#ESMO22
has now officially come to an end. Many thanks to all of you who made this happen, the participants, onsite or online, the Scientific Committee, the Chairs & Speakers, & ESMO staff. Safe travels, & see you in Madrid for
#ESMO23
Thanking
#ESMO23
Social Media Ambassadors for their enthusiastic reporting from the Congress.
Are you following the ESMO Ambassador list on X? Look out for their posts and join the conversation.
ESMO Executive Board elections results:
📍Fabrice André: ESMO President 2025-2026
📍Nadia Harbeck: ESMO Director of Education 2023-2024
📍Evandro de Azambuja: ESMO Director of Membership 2023-2024
📍Jean-Yves Blay: ESMO Director of Public Policy 2023-2024
It is with great sadness that we join the oncology community in mourning the passing of our dear colleague & friend Gouri Bhattacharyya, a driving force within the ESMO Global Policy Committee & member of the
@ESMO_Open
Editorial Board. Our thoughts are w/ his loved ones & ISMPO
Newly-published recommendations on the use of
#ctDNA
: guidance to medical
#oncologists
on clinical applications, & addressing main technical aspects of testing & providing quality standards required for decision-making.
#precisionmedicine
#ESMO20
has started, albeit in a different format, yet still delivering on its mission: to be the platform where
#oncologists
connect & share the latest
#cancer
research. We are meeting as
#ONEoncologycommunity
to bring innovation to cancer pts. Join us 👉
📣 Hola Madrid!
#ESMO23
will be opening its onsite and online doors today. Latest science, practice-changing data & state-of-the-art education are heading your way, bringing the oncology community together once again. 🙌
#OncTwitter
ESMO expert consensus: do not discontinue or delay cancer treatment that may impact on overall survival. ESMO’s comprehensive set of recommendations address open questions on how to manage
#cancer
care in the
#COVID19
era
@Annals_Oncology
Based on two studies at
#ESMO23
,
#PhysicalActivity
levels of patient's w/ cancer remain mostly low & the topic does not get discussed w/ their oncologist. Patient education & interventions to encourage PA should be routinely initiated by oncologists to support patients.
#ESMO20
: Don't miss Europe's most prestigious congress for oncology stakeholders 🌟 ESMO Members: free registration & unlimited access to meeting resources. Thinking of joining? 👉Watch what the virtual format offers:
#ESMO18
is slowly coming to a close. The science, the education, the peer connections; everything came together for an exceptional congress. Many thanks to all of you - a united community with one common vision, improving patient outcomes
#IWD2020
: The ESMO President is a woman, half of ESMO Executive Board are women, 47% ESMO members are women, 35% of speakers at ESMO’s annual congress are women. "2 forge an equal world though we need 2 continue"
@Piuchagarrido
, ESMO Women 4 Oncology Committee Chair
#women4onco
ESMO announces the publication of ESMO-GROW, the first oncology-specific reporting guidance for
#RWEstudies
, representing a key step forward to increase quality standards and harmonised interpretations in RWD publications in
#oncology
.
👉
#Covid19
: ESMO recommendations for
#cancer
patient management during the pandemic. Recommendations should be used as guidance for prioritising various aspects of
#cancercare
so to mitigate negative effects of pandemic on the management of cancer patients
#ESMO22
: All 1,835 accepted abstracts now online 🙌 Available open access & searchable by title/author
Still thinking about attending? Remember the LIVE Plus, Congress format allows participation in person (Paris) or online 🔗
#ESMO19
: Women for
#oncology
Award to Cristiana Sessa. Inspirational words on what she has learnt throughout her career. Education & mentors key to helping women gain self-confidence. National incentives pivotal. Take risks & believe in yourself!
#women4onco
#WorldCancerDay
: we must remember that everyone can play a part in the fight against
#cancer
& that working 2gether is crucial 4 effective solutions. I am Josep Tabernero, ESMO President, & I will advocate 2 make cancer care sustainable
#IAmAndIWill
@uicc
#WCGIC2022
:Results of the TRIPLETE study highlight the importance of performing randomised clinical trials to avoid unnecessary toxicity. Evidence-based care is the best care we can provide.
👇Learn more in the
#VisualAbstract
@DrAngelaLamarca
The much-anticipated ESMO Clinical Practice Guideline for the diagnosis, staging and treatment of
#metastaticbreastcancer
just published; a milestone for translation of recent research into practical improvements to patient care.
#precisionmedicine
#bcsm
'We currently have a dual responsibility: provide the best care to pts during
#Covid19
& maintain the pace of research. I assure you
#ESMO20
will go ahead, just in a different format, & I truly hope you will join me in making
#ESMO20
a milestone moment'
Biliary tract cancer ESMO Clinical Practice Guideline: Updated recommendations on adjuvant therapy, comprehensive genetic profiling, & use of targeted therapies & immunotherapies in first-line setting
#cholangiocarcinoma
#biliarycancer
#ESMO18
: Snake oil sold as Science: How to protect patients from
#pseudoscience
- fantastic session - lively discussions on the right to evidence-based medicine and correct information to patients
📣
#ESMO21
: Ground-breaking new data to be presented at the ESMO Congress 2021. Take a look at the full programme to find out more:
👉 Register here:
#oncology
#cancerresearch
#ESMO21
: under present conditions, & in keeping with our collective responsibility to help contain
#Covid19
& protect
#cancer
patients,
#oncology
professionals & the health systems that support them, the ESMO Congress 2021 will have to proceed virtually
#ESMOAsia19
: Atezolizumab in Combination with Bevacizumab Provides Superior Outcome Compared with Sorafenib in Unresectable
#HCC
:
#IMbrave150
results may be practice changing in first-line setting for unresectable
#hepatocelluarcarcinoma
👉
Delighted to announce the ESMO awards 2020 winners! ESMO Award 2020: Hans-Joachim Schmoll. ESMO Award for Translational Research 2020: Antoni Ribas. ESMO Women for Oncology Award 2020: Caroline Robert. ESMO Lifetime Achievement Award 2020: Nadia Harbeck
👉
ESMO announced the recipients of the 2022 ESMO Society Awards. These four prestigious distinctions recognise the work and dedication they have put into improving the field of oncology.
👉
ESMO President Elect
@peters_solange
on receiving the 2019 Bonnie J. Addario Lectureship Award 'It is very rewarding that prof achievements are recognised by patients and survivors, it truly means that the efforts done have had an impact on their lives'
ESMO Congress 2023 Opening Press Conference officially opens the doors of
#ESMO23
with dozens of practice-changing studies with the potential to improve
#CancerCare
. A warm welcome to everyone!
KEYNOTE-826:
#immunotherapy
in combo w/ chemo had received accelerated regulatory approval for PDL1+ metastatic
#cervicalcancer
. New data presented at
#ESMO21
show an 📈PFS & OS w/ addition of pembrolizumab 2 chemo regardless of PDL1 expression 👉
#GynCSM
#ESMOBreast20
Many thanks to all +8K participants 4 your patience today as we tackled the steep learning curve that is virtual! Sorry for early technical issues; we have made the first 4 sessions, those mainly impacted, available on demand 4 all delegates
#ESMOBreast20
: Due to the
#Covid19
situation, it is not possible to proceed w/ the ESMO Breast Cancer Congress in its original format; however an ESMO event on
#breastcancer
will happen in a new format - The ESMO Breast Cancer Virtual Meeting 😀 More here
The first-ever ESMO Advanced Course on
#cholangiocarcinoma
just took place in Barcelona 📣exploring challenges, tx strategies, roles of locoregional therapy &
#immunotherapy
, currently-available & novel targeted therapies & tx options
Many thanks to all…
#covid19
: Four key actions for
#oncology
professionals to continue to deliver optimal care to
#cancer
patients & maintain high-quality cancer services in such extreme circumstances 👉
#ESMO23
: All regular abstracts (proffered paper & mini oral sessions) and posters can be found online👉 The countdown is on ⏰ Just four days before Congress begins. If you haven’t registered yet there's still time to do so 👉…
New: The Clinical Practice Guideline on
#Insomnia
in adult patients with cancer includes evidence-based recommendations and treatment algorithms for screening and managing insomnia in patients and survivors.
@ESMO_Open
@curijoey
@LloydwilliamsM
#ESMO18
@TonyMok9
Lifetime achievement: two things I have learned - my duty is to create hope for
#patients
and my achievement is to create hope with likeminded friends
#ESMO23
: Do not miss the insights on the latest
#OncologyResearch
brought to you by the ESMO Social Media Ambassadors. Stay abreast of the latest scientific findings and join the conversation.
📌
One of our ESMO Research Fellowships 2020 starting😀
@FrancescoSche20
will be looking into ‘Prognostic & therapeutic significance of treatment-induced intrinsic subtypes & genomic changes in luminal
#breastcancer
’ w/ mentor
@prat_aleix
👉
#bcsm
eUpdate to the '
#RenalCellCarcinoma
: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': The combination of cabozantinib and nivolumab is now recommended as frontline therapy for advanced disease
#WorldCancerDay
: 'We need to fight for and state that no limitations cannot be challenged… and create more equity in the future in the way that we treat
#cancer
worldwide, delivering to patients optimal cancer care'
@peters_solange
#IAmAndIWill
Olaparib shows durable clinical benefits in HRD+ patients with advanced
#OvarianCancer
: results from the phase III SOLO1/GOG-3004 and PAOLA-1/ENGOT-ov25 trials at
#ESMO22
.
To know more👉
#ESMO20
: Top 10 most-consulted abstracts on OncologyPRO since the Science Weekend kick off 😀 How many of them made your list? Check out all abstracts here
Updated ESMO Clinical Practice Guideline on
#Venousthromboembolism
in cancer pts. Primary thromboprophylaxis may be considered in HR ambulatory pts using validated risk models. Anticoagulant
#VTE
tx effective but may be associated w/ increased bleeding.
#ESMO22
: Meeting resources now available on OncologyPRO. Access +2,700 slides, webcasts, abstracts & ePosters - practice changing data and state-of-the-art educational content from more than 20 tracks
#MedTwitter
#OncTwitter
We are delighted to announce
@antoniomarraMD
as 1st recipient of the ESMO José Baselga Clinician Scientist Fellowship, aiming to help young oncologists develop as clinician scientists. To be awarded at the
#ESMO22
YO Fellowship Session (11/9)
@IEOufficiale
#covid19
&
#cancer
: The 'ESMO Guide for Patients:
#Cancer
care during the
#COVID19
pandemic' 👉 Designed to help
#cancerpatients
, relatives & caregivers understand how the pandemic can affect cancer care, how to lower the risk of infection & more 👉